Infectious complications distribution following CLL1 CAR-T cell therapy for acute myeloid leukemiass
Jianmei Xu(Tianjin Medical University), Mingfeng Zhao(Tianjin First Center Hospital), Hairong Lyu(University of Bristol), Xiaomei Zhang(Tianjin First Center Hospital), Yu Zhang(Tianjin First Center Hospital), Xia Xiao(Hebei Medical University), Xiaoyuan He(Nankai University), Shujing Guo(Tianjin Medical University), Xiaoxue Shi(Tianjin Medical University), Huan Zhang(Tianjin First Center Hospital), Yifan Zhao(Tianjin Medical University)
Cited by 6
Related Papers
Sporotrichosis between 1898 and 2017: The evolution of knowledge on a changeable disease and on emerging etiological agents.
|Medical Mycology|2018|170
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149
Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
|Cell Death and Disease|2013|129
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
|Frontiers in Oncology|2020|82